Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06771830 · ClinicalTrials.gov registry record · NA
Evaluation of Pediatric eCART Implementation
A NA study of Sepsis and Pediatric ALL, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 30,000
- Enrollment target
- 1
- Study location
NCT06771830: Recruiting NA study of Sepsis and Pediatric ALL, sponsored by University of Wisconsin, Madison.
NCT06771830 is a NA study of Sepsis and Pediatric ALL that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 30,000 participants, above the 6,231-participant average among 90 other Sepsis trials with a reported enrollment target (381% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06771830, a NA study of Sepsis and Pediatric ALL, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 30,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study comparing 3 years of retrospective data (pre-implementation) to 2 years of prospective data after the implementation of a pediatric version of Electronic Cardiac Arrest Risk Triage (pediatric eCART), a clinical decision support (CDS) tool that uses electronic health records (EHR) to identify patients with high risk for life threatening outcomes. Up to 30,000 encounters with pediatric patients will be assessed. Acceptability of the pediatric eCART intervention will also be measured from pediatric nurse clinicians.
Conditions Studied
Interventions
- DEVICE Pediatric eCART
Study Locations (1)
Wisconsin
- American Family Children's Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06771830 shows while recruiting
NCT06771830 is an interventional study that assigns participants to a tested intervention. Its 30,000 participants enrollment target places it among the larger protocols in the corpus, above the 6,231-participant average among 90 other Sepsis trials with a reported enrollment target (381% higher).
The record links to 2 conditions, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Pediatric eCART is the first listed.
NCT06771830 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06771830 about?
NCT06771830 is a clinical study titled "Evaluation of Pediatric eCART Implementation". This is a study comparing 3 years of retrospective data (pre-implementation) to 2 years of prospective data after the implementation of a pediatric version of Electronic Cardiac Arrest Risk Triage (pediatric eCART), a clinical decision support (CDS) tool that uses electronic health records (EHR) to ...
What is the current status of trial NCT06771830?
This trial is currently recruiting. It is a NA study. The enrollment target is 30,000 participants. The study started on 2025-12-01. Estimated completion is 2027-12.
What conditions does trial NCT06771830 study?
This clinical trial studies the following conditions: Sepsis, Pediatric ALL.
What interventions are being tested in trial NCT06771830?
The interventions under investigation include: Pediatric eCART (DEVICE).
Who is sponsoring clinical trial NCT06771830?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06771830 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06771830's enrollment target sits among peer trials
30,000 5th of 90 higher than 85 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI